Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
Patents for C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
11/2002
11/12/2002US6479659 Improved process and novel intermediates to endothelin receptor antagonists
11/12/2002US6479554 Immunotherapeutic agents
11/12/2002US6479548 Substituted stilbenes as glucose uptake enhancers
11/12/2002US6479484 Substituted 2-aminoacetamides and the discovery that these compounds act as blockers of sodium channels; pain relievers, treatment of arrythmia, local anesthetics
11/12/2002US6479192 Non-aqueous electrolyte for electrochemical systems and lithium secondary battery comprising the same
11/12/2002CA2324959C Phthalimido compounds as intermediates for producing substance p receptor antagonists
11/07/2002WO2002057227A3 Process of enantiomerically enriched flavor and fragrance components
11/07/2002US20020165393 Kinetic resolutions of chiral 2- and 3-substituted carboxylic acids
11/07/2002US20020165203 Enzyme inhibitors; antiinflammatory agents; rheumatic diseases; antidiabetic agents
11/06/2002EP1254101A1 Propionic acid derivatives and their use in the treatment of diabetes and obesity
11/06/2002CN1378446A Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
11/06/2002CN1377883A Cosmetic preparation containing light stable UV-A light filter agent
11/05/2002US6476264 N-(4-carbamimidoyl-phenyl)-glycine derivatives
11/05/2002US6476240 Polymers derived from an unsaturated fused cyclic hydrocarbon (such as perhydro-2,3-didehydro-1,4:5,8-dimethanonaphthalene) joined by a linker to an ester group having one or two protected hydroxyls; use as photoresist
11/05/2002US6476237 Subjecting crude alkylene carbonate to evaporation in first evaporator to form a first evaporator overhead containing alkylene carbonate and first evaporator bottoms stream containing catalyst, and recycling; evaporation
11/05/2002US6476026 Compounds and compositions as protease inhibitors
10/2002
10/31/2002WO2002085843A2 Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds
10/31/2002WO2001056563A9 Adamantyl derivatives as anti-cancer agents
10/31/2002US20020161252 Zinc complex with a chiral ligand, such as diethylzinc((S,S)-N-N'-ethylene-bis-(1-phenylethylamine))
10/31/2002US20020161237 (Z)-2-((2-bromo-4-(((3-hydroxybenzyl)amino)carbonyl)benzoyl) -amino)pent-2-enoic acid, for example; useful for treating psoriasis
10/31/2002US20020161236 2-methyl-3-(protected hydroxy) benzyl chloride; use making nelfinavir mesylate
10/31/2002US20020161206 For inhibiting tumor cell growth
10/31/2002CA2443946A1 Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds
10/30/2002EP1253147A1 Process for preparing piperonal
10/30/2002EP1253138A2 Novel tertiary amine compounds having an ester structure and processes for preparing same
10/30/2002EP1251822A1 Novel coupler for use in oxidative hair dyeing
10/30/2002CN1376659A Process for preparing chiral desubstituted carbinol with high selectivity
10/30/2002CN1093529C Preparation of 1,5-di-o-coffeic acyl quininic acid derivative
10/29/2002US6472570 Method for the asymmetric dihydroxylation of olefins, using osmium catalysts
10/29/2002US6472545 For therapy of diabetes, obesity
10/29/2002US6472407 α and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
10/29/2002US6472349 Pyridine-2,3-dicarboxylic acid diamides
10/24/2002WO2002083624A1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
10/24/2002WO2002083606A1 A linker system for the synthesis and screening of combinatorial libraries of polyamine derivatives on water compatible supports
10/24/2002US20020156300 Reacting chemical intermediate with reducing agent; neuraminidase inhibitor
10/24/2002US20020156295 Coordination catalyst containing ligand
10/24/2002US20020156061 Administering to a mammal a matrix metalloproteinase inhibiting amount of derivatives of isophthalic acid, isophthalic acid ester or isothalamide compounds to treat cancer, rheumatic arthritis atherosclerosis and osteoporosis
10/24/2002US20020155588 Very large scale immobilized polymer synthesis
10/23/2002CN1376176A Polycarbonate composition resistant to gamma radiation
10/23/2002CN1093126C Improved process for the synthesis of protected esters of (s)-3,4-dihydroxytubyric acid
10/22/2002US6469185 Perfluorodioxoles
10/22/2002US6469047 Tyrosine derivatives
10/22/2002US6469005 Propargylether derivatives
10/17/2002WO2002081463A1 Antagonists of mcp-1 function and methods of use thereof
10/17/2002WO2002081435A1 Sulphones which modulate the action of gamma secretase
10/17/2002WO2001096283A9 Hiv integrase inhibitors
10/17/2002US20020151744 Kinetic resolutions of chiral 2-and-3-substituted carboxylic acids
10/17/2002US20020151570 Thiosulfonic acid S-esters as agents for protecting material
10/17/2002US20020151567 Preparation of N-methylparoxetine and related intermediate compounds
10/17/2002US20020151566 Phosphodiesterase 4 inhibitors
10/17/2002DE10104770C1 (1,1'-Biphenyl)-2,4-diamin-Derivate enthaltende Färbemittel für Keratinfasern sowie neue (1,1'-Biphenyl)-2,4-diamin-Derivate (1,1'-biphenyl) -2,4-diamine derivatives containing a colorant for keratin fibers and new (1,1'-biphenyl) -2,4-diamine derivatives
10/17/2002CA2442776A1 Antagonists of mcp-1 function and methods of use thereof
10/16/2002EP1249233A1 Npyy5 antagonists
10/16/2002EP0934316B1 Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use
10/16/2002EP0813542B1 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
10/16/2002CN1374305A Alkoxy derivative of safrole oxide 2-alkoxy-piperonyl ethanol and its prepn and application
10/16/2002CN1374304A Intermediate of high-carbon saccharide compound and its synthesis and use
10/16/2002CN1374287A Process for producing 2.7-dimethyl-2,4,6-sarohornene aldehyde mono aldehyde acetal
10/15/2002US6465663 Ethyl (e)-4-(2-(5,6-dihydro-5,5-dimethyl-naphthalen-8(7h)-one-2 -yl)ethenyl)benzoate and ethyl (e)-4-(2-(5,6-dihydro-5,5-dimethyl-8-(phenylthio)-naphthalenyl)ethenyl) benzoate
10/15/2002US6465661 Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors
10/15/2002CA2112690C Amino acid derivative
10/10/2002WO2002079185A1 Process for producing (dioxolenon-4-yl)methyl ester derivative
10/10/2002WO2002079148A2 Multifunctional carbonates and derivatives
10/10/2002WO2002079144A1 (p-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds
10/10/2002WO2002079143A1 N-phenpropylcyclopentyl-substituted glutaramide derivatives as nep inhibitors for fsad
10/10/2002WO2002079126A1 Cross-metathesis reaction of functionalized and substituted olefins using group 8 transition metal carbene complexes as metathesis catalysts
10/10/2002WO2002079124A2 Method of producing high yield alditol acetals with mineral acids and surfactants
10/10/2002WO2002057215A3 Sodium channel modulators
10/10/2002WO2001072685A9 Polyamine analogues as cytotoxic agents
10/10/2002US20020147349 Catalytic carbonation of alkylene oxide with carbon dioxide; distillation
10/10/2002US20020147336 Glucocorticoid receptor modulators
10/10/2002US20020147290 Cyclic acetal compound, polymer, resist composition and patterning process
10/10/2002US20020147182 13-substituted methacycline compounds
10/10/2002DE10115994A1 (p-Amino-hydroxyphenyl)acrylamid-Derivate und diese Verbindungen enthaltende Färbemittel (P-amino-hydroxyphenyl) acrylamide derivatives and compositions containing these compounds colorant
10/10/2002CA2443304A1 (p-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds
10/10/2002CA2442368A1 Cross-metathesis reaction of functionalized and substituted olefins using group 8 transition metal carbene complexes as metathesis catalysts
10/10/2002CA2437113A1 N-phenpropylcyclopentyl-substituted glutaramide derivatives as nep inhibitors for fsad
10/09/2002EP1246795A2 Antibacterial agents
10/09/2002EP1246625A2 Methods and compositions for mitigating pain using nitrate esters
10/09/2002CN1373754A Antibacterial agents
10/09/2002CN1092191C Method for manufacture of cyclocarbonates
10/09/2002CN1092022C Microbicides
10/08/2002US6462076 Beta-amino acid nitrile derivatives as cathepsin K inhibitors
10/08/2002US6462064 Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents, especially for cervical cancers and dysplasias
10/08/2002CA2271396C Process for the preparation of shikimic acid and its derivatives
10/03/2002WO2002076964A1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
10/03/2002WO2002076929A1 Aryl and biaryl compounds having mch modulatory activity
10/03/2002WO2002076926A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/03/2002US20020143130 Monomer and polymer for photoresist, photoresist composition, and phosphor layer composition for color cathode ray tube
10/03/2002US20020143036 Pentafluorobenzenesulfonamides and analogs
10/03/2002US20020142969 Using didepsipeptide for the control of endoparasites in medicine and veterinary medicine
10/03/2002CA2436351A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/02/2002EP1244646A1 Dinitrile intermediates for the synthesis of omapatrilat and methods for producing same
10/02/2002EP1244451A1 Substituted piperazine and piperidine calcium channel blockers
10/01/2002US6458969 Process to provide high purity alkylene carbonate though use of multiple distillations wherein the unused fractions are recycled to the reactor. the high purity alkylene carbonate may be further purified by use of carbon to produce
10/01/2002US6458785 Aids therapy
09/2002
09/26/2002WO2002074738A2 Spiro-cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteinases and tnf-alpha converting enzyme (tage)
09/26/2002WO2002074298A1 Il-6 production inhibitors
09/26/2002WO2002074296A1 Remedies for solid cancer containing hydroxamic acid derivatives as the active ingredient
09/26/2002WO2002046507A3 Onium salts and the use therof as latent acids
1 ... 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 ... 183